The world is slowly recovering from the COVID-19 pandemic. But the blow it struck to the rule of law remains persistent and widespread, according to fresh...
Greenwald: Meet The Consortium Imposing The Growing Censorship Regime Authored by Glenn Greenwald via Substack, The rapid escalation of online...
A recent preprint suggesting SARS-CoV-2 came from a lab has reignited the fierce debate over the origins of the virus.
Engaging a CRO is the start of a long-term relationship, and it is crucial to get off on the right foot.
Debt is becoming unaffordable.
Overview: The yen and sterling are trading quietly after the recent drama, but with the Party Congress ending, the Chinese yuan has been permitted to fall...
Ferguson: How Cold War II Could Turn Into World War III Authored by Niall Ferguson, op-ed via Bloomberg, History shows that nothing causes...
Rishi Sunak is taking over as UK prime minister from Liz Truss during very difficult economic times.
US Futures Stabilize After Rollercoaster Session As Yuan, Chinese Stocks Crater US stock futures steadied following a rollercoaster move earlier...
UK Tory Leadership Race Begins, Labour Demands Early Election Authored by Katabella Roberts via The Epoch Times, Following UK Prime Minister Liz...
What’s the latest thinking in fiscal and monetary policy? The Hutchins Roundup keeps you informed of the latest research, charts, and speeches. Want...
Forget Oil, The Real Crisis Is Diesel Inventories: The US Has Just 25 Days Left For all the drama surrounding Biden's latest Strategic Petroleum...
European Auto Stocks Rally After Sales Rise For Second Month In A Row European auto stocks are on watch midweek after new car sales in the...
Luongo: The Fed Is Exposing The Lies Of Two Generations Of People In Power Authored by Tom Luongo via Gold, Goats, 'n Guns blog, Fed Watch:...
One-Third Of Ukraine's Power Stations Destroyed As WHO Warns Of "Brutal" Winter Ahead Ukrainian President Volodymyr Zelensky announced Tuesday...
Moderna is calling it quits on its current agreement with Gavi, the Vaccine Alliance, meaning an original deal for up to 500 million doses of the...
EU Prosecutor Opens Probe Into COVID Vaccine Purchases Two weeks after Pfizer CEO bailed on EU testimony in the wake of a report highlighting...
In the first study of its kind, German researchers have shown that the COVID pandemic saw a huge drop in the number of patients being admitted...
A healthy diet and avoiding the news helped prevent anxiety and depression during COVID, even better than interacting with friends, following a routine,...
Amgen estimates that biosimilars resulted in $3.2 billion in savings last quarter alone, according to its latest trend report. And though the last two...
Bayer’s big-selling contraceptive Mirena has been approved in Europe to provide up to eight years of pregnancy protection, The post Bayer get EU nod...
Pfizer Exec Admits Under Oath: 'We Never Tested COVID Vaccine Against Transmission' A senior Pfizer executive has admitted under oath that...
Futures Bounce, Gilts Tumble In BOE-Driven Rollercoaster Session US stocks were set to bounce, ending a brutal five-day losing streak, amid...
Three environmentally friendly industrial stocks to buy for war or peace are seeking to give birth to breakthroughs that will position them for bright...
Amid what one member of the European Parliament called “SMS-gate,” a Pfizer executive on Monday denied that the company’s vaccine deal with the bloc...
The pharmaceutical giant, still riding high on the sales of Comirnaty and Paxlovid, is looking to a future of innovative oncology drugs and vaccines based...
Amgen is equipped with a broad and diverse product portfolio, commercial capabilities, and levers for delivering mid-single digit revenue growth over this...
2022 has been marked by the first year of leadership under CEO Joaquin Duato and the anticipated separation of the company’s consumer health busines...
Targeted business development acquisitions, improvements in R&D and operating performance, and a strengthened post-demerger balance sheet are creating...
A strong product pipeline and increased group sales confirm that Roche is on the right growth path.